ANTIGENIC SIMILARITIES BETWEEN BRAIN COMPONENTS AND BACTERIA CAUSING MENINGITIS: Implications for Vaccine Development and Pathogenesis
References (34)
- et al.
Bacterial meningitis: newer concepts of pathophysiology and neurologic sequelae
Pediatr Clin North Am
(1976) Vaccines for the prevention of encapsulated bacterial diseases: current status, problems and prospects for the future
Immunochemistry
(1978)- et al.
Preparation and fractionation of glycopeptides
Methods Enzymol
(1982) Occurrence of unique polysialosyl carbohydrate units in glycoproteins of developing brain
J Biol Chem
(1982)Ammonium sulfate and polyethylene glycol as reagents to separate antigen from antigen-antibody complexes
Methods Enzymol
(1980)- et al.
Studies on the meningococcal polysaccharides. I Composition and chemical properties of the group A polysaccharide
J Biol Chem
(1971) - et al.
Structural determination of the sialic acid polysaccharide antigens of Neisseria meningitidis serogroups B and C with carbon 13 nuclear magnetic resonance
J Biol Chem
(1975) - et al.
Sialic acid polysaccharide antigens of Neisseria meningitidis and Escherichia coli: esterification between adjacent residues
Carbohydrate Res
(1981) - et al.
Isolation and characterisation of two isomers of brain tetrasialogangliosides
J Biol Chem
(1979) - et al.
Microbial polysaccharides
Meningococcal disease, still with us
Rev Infect Dis
(1983)
Étude épidémiologique des cas de méningites purulentes hospitalisés àDakar pendant la décennie 1970-1979
Bull WHO
(1981)
Human immunity to the meningococcus. III. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides
J Exp Med
(1969)
Clinical vaccine of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age
N Engl J Med
(1977)
Report of a WHO Study Group
WHO Techn Rep Ser
(1976)
Should we plan a general childhood vaccination against bacterial meningitis?
Develop Biol Standard
(1979)
Immunologic response of man to group B meningococcal polysaccharide vaccines
J Infect Dis
(1972)
Cited by (680)
The genomic epidemiology of Neisseria meningitidis carriage from a randomised controlled trial of 4CMenB vaccination in an asymptomatic adolescent population
2024, The Lancet Regional Health - Western PacificMeningococcal Vaccination of Adolescents in the United States: Past Successes and Future Considerations
2024, Journal of Adolescent HealthA new era for equity in meningococcal disease prevention
2023, The Lancet Infectious DiseasesMeningococcal factor H-binding protein: implications for disease susceptibility, virulence, and vaccines
2023, Trends in Microbiology
Copyright © 1983 Published by Elsevier Ltd.